US 7527802
Vaccine for transcutaneous immunization
granted A61KA61K2039/521A61K2039/54
Quick answer
US patent 7527802 (Vaccine for transcutaneous immunization) held by The United States of America as represented by the Secretary of the Army expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/521, A61K2039/54, A61K2039/541, A61K2039/55544